News

Filter

Current filters:

GlobalTivicay

1 to 9 of 97557 results

Valneva grants license to Immune Targeting Systems for the development of hepatitis B vaccine

29-01-2015

France-based biotech firm Valneva and UK company Immune Targeting Systems (ITS) have signed an exclusive…

Anti-viralsBiotechnologyGlobalImmune Targeting SystemsLicensingValneva

RegeneRx links with G-treeBNT to develop RGN-259 in the USA

29-01-2015

US biotech firm RegeneRx Biopharmaceuticals has entered into agreements with South Korea-based G-treeBNT…

BiotechnologyG-treeBNTLicensingMergers & AcquisitionsOphthalmicsRegeneRxRGN-259USA

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

TxCell receives latest 1 million-euro milestone payment in OvaSave license agreement

29-01-2015

French biotech company TxCell has received the latest 1 million-euro milestone payment ($1.13 million)…

BiotechnologyGastro-intestinalsLicensingOvaSaveResearchTxCell

Long-term solutions needed for kidney disease, says EAF report

Long-term solutions needed for kidney disease, says EAF report

29-01-2015

Greater education and support for non-specialist health care professionals is needed to ensure the accurate…

EuropeHealthcareNephrology and HepatologyOtsuka PharmaceuticalPharmaceutical

Applied Molecular Transport inks research and license agreement with Janssen on IBS therapy

Applied Molecular Transport inks research and license agreement with Janssen on IBS therapy

28-01-2015

Biopharma company Applied Molecular Transport has entered into a research collaboration and license agreement…

Applied Molecular TransportGastro-intestinalsJanssenJohnson & JohnsonLicensingPharmaceutical

US House Energy & Commerce Committee releases 21 Century Cures Act discussion draft

US House Energy & Commerce Committee releases 21 Century Cures Act discussion draft

28-01-2015

The promised January 2015 release of a discussion draft of legislation to implement the 21st Century…

PatentsPharmaceuticalPoliticsResearchUSA

AnaMar to focus on severe inflammation and fibrosis

28-01-2015

Swedish privately-held biopharma company AnaMar says it will focus pipeline development on severe inflammation…

AnaMarBiotechnologyInflammatory diseasesLicensingResearchRespiratory and Pulmonary

1 to 9 of 97557 results

Back to top